Placebo SC
Placebo SC is a pharmaceutical drug with 54 clinical trials. Currently 6 active trials ongoing. Historical success rate of 83.0%.
Success Metrics
Based on 39 completed trials
Phase Distribution
Phase Distribution
31
Early Stage
8
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.3%
39 of 48 finished
18.8%
9 ended early
6
trials recruiting
54
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
Clinical Trials (54)
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants
To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate
Study of ALXN1820 in Healthy Adult Participants
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
A Study of Mirikizumab (LY3074828) in Healthy Participants
A Study of Mirikizumab in Healthy Chinese Participants
Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 54